BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 10874635)

  • 21. Fragile X syndrome screening of families with consanguineous and non-consanguineous parents in the Iranian population.
    Pouya AR; Abedini SS; Mansoorian N; Behjati F; Nikzat N; Mohseni M; Nieh SE; Abbasi Moheb L; Darvish H; Monajemi GB; Banihashemi S; Kahrizi K; Ropers HH; Najmabadi H
    Eur J Med Genet; 2009; 52(4):170-3. PubMed ID: 19361583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical and molecular screening for fragile X syndrome in 300 patients with non-specific mental retardation].
    Jara L; López M; Mellado C; Aspillaga M; Avendaño I; Blanco R
    Rev Med Chil; 1998 Aug; 126(8):911-8. PubMed ID: 9830742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fragile X syndrome (review).
    Pimentel MM
    Int J Mol Med; 1999 Jun; 3(6):639-45. PubMed ID: 10341296
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New methods for the diagnosis of fragile X syndrome: a study of the FMRP in blood and hair].
    Ramos-Fuentes FJ
    Rev Neurol; 2001 Oct; 33 Suppl 1():S9-S13. PubMed ID: 12447812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular diagnosis and genetic counseling for fragile X mental retardation.
    Pandey UB; Phadke SR; Mittal B
    Neurol India; 2004 Mar; 52(1):36-42. PubMed ID: 15069237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A methylation PCR approach for detection of fragile X syndrome.
    Panagopoulos I; Lassen C; Kristoffersson U; Aman P
    Hum Mutat; 1999; 14(1):71-9. PubMed ID: 10447261
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prenatal diagnosis and carrier screening for fragile X by PCR.
    Brown WT; Nolin S; Houck G; Ding X; Glicksman A; Li SY; Stark-Houck S; Brophy P; Duncan C; Dobkin C; Jenkins E
    Am J Med Genet; 1996 Jul; 64(1):191-5. PubMed ID: 8826474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening of rural children in West Bengal for fragile-X syndrome.
    Dutta S; Das M; Bhowmik AD; Sinha S; Chattopadhyay A; Mukhopadhyay K
    Indian J Med Res; 2009 Dec; 130(6):714-9. PubMed ID: 20090132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular screening of fragile X (FRAXA) and FRAXE mental retardation syndromes in the Hellenic population of Greece and Cyprus: incidence, genetic variation, and stability.
    Patsalis PC; Sismani C; Hettinger JA; Boumba I; Georgiou I; Stylianidou G; Anastasiadou V; Koukoulli R; Pagoulatos G; Syrrou M
    Am J Med Genet; 1999 May; 84(3):184-90. PubMed ID: 10331587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fragile site X chromosomes in mentally retarded boys.
    Moon HR; Moon SY
    J Korean Med Sci; 1993 Jun; 8(3):192-6. PubMed ID: 8240748
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Fragile X syndrome. Clinical analysis of 300 Chilean patients with unspecific mental retardation].
    Aspillaga M; Jara L; Avendaño I; López M
    Rev Med Chil; 1998 Dec; 126(12):1447-54. PubMed ID: 10349158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of pre-mutation of X chromosome CGG trinucleotide repeats on brain anatomy.
    Moore CJ; Daly EM; Tassone F; Tysoe C; Schmitz N; Ng V; Chitnis X; McGuire P; Suckling J; Davies KE; Hagerman RJ; Hagerman PJ; Murphy KC; Murphy DG
    Brain; 2004 Dec; 127(Pt 12):2672-81. PubMed ID: 15483045
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved fluorescent PCR-based assay for sizing CGG repeats at the FRAXA locus.
    Houdayer C; Lemonnier A; Gerard M; Chauve C; Tredano M; de Villemeur TB; Aymard P; Bonnefont JP; Feldmann D
    Clin Chem Lab Med; 1999 Apr; 37(4):397-402. PubMed ID: 10369109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 15-item checklist for screening mentally retarded males for the fragile X syndrome.
    Butler MG; Mangrum T; Gupta R; Singh DN
    Clin Genet; 1991 May; 39(5):347-54. PubMed ID: 1860251
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Fragile X syndrome--child's and parent's problem].
    Lisik MZ; Janas-Kozik M; Krupka-Matuszczyk I; Sieroń AL
    Psychiatr Pol; 2011; 45(3):357-65. PubMed ID: 22232966
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Molecular biologic screening test (PCR) for fragile X syndrome].
    Kovács E; Morava E; Nádasi E; Czakó M; Melegh B; Kosztolányi G
    Orv Hetil; 1998 Dec; 139(52):3121-3. PubMed ID: 9914733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systematic screening for fragile X syndrome in a cohort of 574 mentally retarded children.
    Gérard B; Le Heuzey MF; Brunie G; Lewine P; Saiag MC; Cacheux V; Da Silva F; Dugas M; Mouren-Simeoni MC; Elion J; Grandchamp B
    Ann Genet; 1997; 40(3):139-44. PubMed ID: 9401101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of the fragile X syndrome among Estonian mentally retarded and the entire children's population.
    Puusepp H; Kahre T; Sibul H; Soo V; Lind I; Raukas E; Ounap K
    J Child Neurol; 2008 Dec; 23(12):1400-5. PubMed ID: 19073844
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular screening for fragile X syndrome in Thailand.
    Limprasert P; Ruangdaraganon N; Sura T; Vasiknanonte P; Jinorose U
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 2():114-8. PubMed ID: 11400746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Screening for the fragile X syndrome among mentally retarded males by hair root analysis.
    Tunçbilek E; Alikasifoğlu M; Aktas D; Duman F; Yanik H; Anar B; Oostra B; Willemsen R
    Am J Med Genet; 2000 Nov; 95(2):105-7. PubMed ID: 11078558
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.